Announcements
- Coloplast A/S - Selskabsmeddelelse nr. 02/2023 - Regnskabsmeddelelse, 1. halvår 2022/23
- Coloplast A/S - Announcement no. 02/2023 - Interim Financial Report, H1 2022/23
- Studie viser signifikant forbedring af blæretømning med Coloplasts Luja™ sammenlignet med konkurrentkateter
- Study shows significant improvement in bladder emptying with Coloplast's Luja™ compared to competitor catheter
- Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons
- Coloplast A/S - Bestyrelsesmedlemmers, direktørers eller nærtstående personers handel med Coloplast-aktier
- Coloplast A/S - Allokering af aktieoptioner
- Coloplast A/S - Allocation of Share Options
- Coloplast lancerer nyt kateter til mænd udviklet til at mindske risikoen for urinvejsinfektioner
- Coloplast launches male catheter designed to reduce the risk of urinary tract infections
More ▼
Key statistics
Short selling activityProvided by S&P Global Market Intelligence
Open | 615.10 |
---|---|
High | 615.10 |
Low | 615.10 |
Bid | -- |
Offer | -- |
Previous close | 615.10 |
Average volume | -- |
---|---|
Shares outstanding | 198.00m |
Free float | 108.81m |
P/E (TTM) | 38.15 |
Market cap | 170.56bn DKK |
EPS (TTM) | 22.58 DKK |
Data delayed at least 15 minutes, as of Nov 26 2018.
More ▼